Connection

Dan Simionescu to Heart Valve Prosthesis

Back to Details
This is a "connection" page, showing publications Dan Simionescu has written about Heart Valve Prosthesis.
Dan Simionescu
Connection Strength
1.508
Heart Valve Prosthesis
  1. Prevention of calcification in bioprosthetic heart valves: challenges and perspectives. Expert Opin Biol Ther. 2004 Dec; 4(12):1971-85.
    View in: PubMed
    Score: 0.208
  2. Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves. J Biomed Mater Res A. 2003 Sep 15; 66(4):755-63.
    View in: PubMed
    Score: 0.191
  3. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study. J Heart Valve Dis. 2003 Mar; 12(2):226-34.
    View in: PubMed
    Score: 0.184
  4. Challenges in Perioperative Animal Care for Orthotopic Implantation of Tissue-Engineered Pulmonary Valves in the Ovine Model. Tissue Eng Regen Med. 2020 12; 17(6):847-862.
    View in: PubMed
    Score: 0.155
  5. Transcatheter mitral valve replacement (TMVR): annular or apical fixation? EuroIntervention. 2020 Aug 07; 16(6):e510-e517.
    View in: PubMed
    Score: 0.154
  6. Stabilized Collagen and Elastin-Based Scaffolds for Mitral Valve Tissue Engineering. Tissue Eng Part A. 2016 11; 22(21-22):1241-1251.
    View in: PubMed
    Score: 0.118
  7. Mapping of glutaraldehyde-treated bovine pericardium and tissue selection for bioprosthetic heart valves. J Biomed Mater Res. 1993 Jun; 27(6):697-704.
    View in: PubMed
    Score: 0.094
  8. Detection of remnant proteolytic activities in unimplanted glutaraldehyde-treated bovine pericardium and explanted cardiac bioprostheses. J Biomed Mater Res. 1993 Jun; 27(6):821-9.
    View in: PubMed
    Score: 0.094
  9. Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. Biomaterials. 2007 Jun; 28(18):2861-8.
    View in: PubMed
    Score: 0.061
  10. Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization. Biomaterials. 2007 Jan; 28(3):496-503.
    View in: PubMed
    Score: 0.059
  11. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. J Heart Valve Dis. 2003 Mar; 12(2):217-25.
    View in: PubMed
    Score: 0.046
  12. Matrix metalloproteinases and tissue valve degeneration. J Long Term Eff Med Implants. 2001; 11(3-4):221-30.
    View in: PubMed
    Score: 0.040
  13. Detergent-based decellularization strategy preserves macro- and microstructure of heart valves. Interact Cardiovasc Thorac Surg. 2018 02 01; 26(2):230-236.
    View in: PubMed
    Score: 0.032
  14. Biochemical pathways of tissue degeneration in bioprosthetic cardiac valves. The role of matrix metalloproteinases. ASAIO J. 1996 Sep-Oct; 42(5):M561-7.
    View in: PubMed
    Score: 0.029
  15. New evolution in mitral physiology and surgery: mitral stentless pericardial valve. Ann Thorac Surg. 1995 Aug; 60(2 Suppl):S433-8.
    View in: PubMed
    Score: 0.027
  16. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. Biomaterials. 2005 Apr; 26(11):1237-45.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.